Impact of maternal, antenatal and birth-associated factors on iron stores at birth: data from a prospective maternal–infant birth cohort by McCarthy, Elaine K. et al.
UCC Library and UCC researchers have made this item openly available.
Please let us know how this has helped you. Thanks!
Title Impact of maternal, antenatal and birth-associated factors on iron stores
at birth: data from a prospective maternal–infant birth cohort
Author(s) McCarthy, Elaine K.; Kenny, Louise C.; Hourihane, Jonathan O'B.;
Irvine, Alan D.; Murray, Deirdre M.; Kiely, Mairead E.
Publication date 2016-12-21
Original citation McCarthy, E. K., Kenny, L. C., Hourihane, J. O. B., Irvine, A. D.,
Murray, D. M. and Kiely, M. E. (2016) 'Impact of maternal, antenatal
and birth-associated factors on iron stores at birth: data from a
prospective maternal–infant birth cohort', European Journal Of Clinical
Nutrition, 71, pp. 782-787. doi: 10.1038/ejcn.2016.255





Access to the full text of the published version may require a
subscription.
Rights © 2016 The Authors. This is a post-peer-review, pre-copyedit
version of an article published in European Journal of Clinical








Impact of maternal, antenatal and birth-associated factors on iron stores at birth: data 
from a prospective maternal-infant birth cohort 
Elaine K McCarthy,1,2 Louise C Kenny,2,3 Jonathan O’B Hourihane,2,4 Alan D Irvine,5,6,7 
Deirdre M Murray,2,4 Mairead E Kiely1,2* 
1Cork Centre for Vitamin D and Nutrition Research, University College Cork, Republic of 
Ireland 
2The Irish Centre for Fetal and Neonatal Translational Research (INFANT), University College 
Cork, Republic of Ireland 
3Department of Obstetrics and Gynaecology, University College Cork, Republic of Ireland 
4Department of Paediatrics and Child Health, University College Cork, Republic of Ireland 
5Department of Clinical Medicine, Trinity College, Dublin, Republic of Ireland 
6Department of Paediatric Dermatology, Our Lady's Children's Hospital, Dublin, Republic of 
Ireland 
7National Children’s Research Centre, Dublin, Republic of Ireland 
*Corresponding author Prof. Mairead Kiely, Cork Centre for Vitamin D and Nutrition 
Research, Room 127, Food Science Building, University College Cork, Cork, Republic of 
Ireland.  Email: m.kiely@ucc.ie Phone: +353214903394 
Running title Factors associated with iron stores at birth 
Conflict of interest No conflicts of interest to declare 
Contributors EKM carried out data collection, database construction and data analysis.  
EKM and MK designed the study and drafted the manuscript.  DMM is the overall principal 
investigator (PI) of the Cork BASELINE Birth Cohort Study and JOBH, LCK, ADI and MK 
are co-PIs and specialist leads.  LCK is the PI of the SCOPE Ireland pregnancy cohort study.  




Background/objectives Low serum ferritin concentrations at birth, which reflect neonatal iron 2 
stores, track through to early childhood and have been associated with poorer 3 
neurodevelopmental outcomes.  We aimed to identify maternal, antenatal and birth-associated 4 
factors that are associated with iron stores at birth in a prospective maternal-infant birth cohort. 5 
Subjects/methods In a population-based, longitudinal, prospective birth cohort in Ireland, 413 6 
maternal-infant dyads with prospectively collected lifestyle and clinical data from 15 weeks’ 7 
gestation had umbilical cord serum ferritin concentrations measured.  Regression models were 8 
developed to identify independent factors associated with cord ferritin concentrations. 9 
Results Median [IQR] cord ferritin concentrations were 185.7 [131.7, 385.5] µg/L and 8% 10 
(n=33) of infants had low iron stores (ferritin <76µg/L) at birth.  Maternal obesity (BMI 11 
≥30kg/m2) at 15 weeks’ gestation (adj. estimate [95% confidence interval (CI)]: -66.4 [-106.9, 12 
-25.9] µg/L, P<0.0001) and delivery by Caesarean section (-38.8 [-70.2, -7.4] µg/L, P=0.016) 13 
were inversely associated with cord ferritin concentrations.  While maternal smoking at 15 14 
weeks’ gestation (adj. odds ratio [95% CI]: 2.9 [1.2, 7.0], P=0.020) and being born small-for-15 
gestational age (3.4 [1.3, 8.9], P=0.012) were associated with an increased risk of low iron 16 
stores (ferritin <76µg/L) at birth. 17 
Conclusions We have identified a number of potentially modifiable lifestyle factors that 18 
influence iron stores at birth, with the important role of overall maternal health and lifestyle 19 
during pregnancy highlighted.  Public health policies targeting women of child-bearing age to 20 
improve nutrition and health outcomes should be prioritised for the health of the next 21 
generation. 22 




Adequate iron status is of particular importance during pregnancy and the first two years of a 25 
child’s life to ensure healthy physical growth, immune function and development of the central 26 
nervous system.1-3  Iron deficiency, with and without anaemia in early childhood has been 27 
consistently associated with lower cognitive, motor and behavioural outcomes, with the effects 28 
long-lasting.4, 5  The interpretation of iron status in neonates can be difficult, due to the changes 29 
in iron metabolism that occur during the first weeks of life, as the infant goes from a relatively 30 
hypoxic intrauterine environment to an oxygen-rich atmosphere.1  However, it is accepted that 31 
ferritin concentrations in umbilical cord blood serum reflect neonatal iron stores.6, 7 32 
Iron stores in neonates have been shown to track through to early childhood; those with the 33 
lowest serum ferritin concentrations at birth continue to have significantly lower ferritin 34 
concentrations up to two years of age.8, 9  Given the altered iron metabolism in the neonatal 35 
period, the thresholds used to define depleted iron stores and iron deficiency in young children 36 
are not applicable to neonates.  However, studies have identified thresholds for use in the 37 
neonatal population, with suggested thresholds for depleted iron stores (<76 µg/L) and iron 38 
deficiency (<35 µg/L, estimated to reflect iron deficiency in the brain) associated with lower 39 
developmental test scores up to five years of age.10, 11 40 
Iron stores at birth are affected by a multitude of factors associated with pregnancy and 41 
childbirth.9, 12  However, few studies have explored multiple potential determinants in a single 42 
cohort and those that have are somewhat limited by study design and size.  Therefore, the aim 43 
of the current study was to explore maternal, antenatal and birth-associated factors that 44 
influence iron stores at birth in an extensively-characterised sample of children from a 45 




Study design and participants 48 
Neonatal participants were recruited as part of the Cork BASELINE (Babies after SCOPE: 49 
Evaluating the Longitudinal Impact using Neurological and Nutritional Endpoints) Birth 50 
Cohort Study (www.clinicaltrials.gov NCT01498965) between March 2008 and January 2011 51 
from women who had participated in the SCOPE (Screening for Pregnancy Endpoints) Ireland 52 
pregnancy study (http://www.anzctr.org.au ACTRN12607000551493).  In SCOPE, 1 768 low 53 
risk, nulliparous women with a singleton pregnancy were recruited prior to 15 weeks’ gestation 54 
from Cork University Maternity Hospital, as part of an international, multicentre study aimed 55 
at investigating early indicators of pregnancy complications.  Specific exclusion criteria for the 56 
SCOPE study included women with a predetermined high risk of preeclampsia, small-for-57 
gestational age (SGA) infants or spontaneous preterm birth because of underlying medical 58 
conditions as outlined in full previously.13, 14 59 
Women in the SCOPE Ireland study provided written informed consent to the BASELINE 60 
Study for their infants (n = 1 537) at 15 weeks’ gestation.  The women and their infants were 61 
followed prospectively throughout pregnancy and through to five years of age, with a detailed 62 
methodology for the BASELINE Study outlined elsewhere.15  Both the SCOPE and 63 
BASELINE studies were conducted in accordance with the Declaration of Helsinki and ethical 64 
approval was granted by the Clinical Research Ethics Committee of the Cork teaching hospitals 65 
(SCOPE: ECM5(10)05/02/2008, BASELINE: ECM 5(9) 01/07/2008). 66 
Data collection 67 
At 15 weeks’ gestation, research midwives collected information on maternal socioeconomic 68 
status, occupation, education, relationship status and a complete medical history.  Information 69 
on nutritional supplement use, recreational activity, cigarette and alcohol use were recorded for 70 
the three month period prior to conception and during the first trimester.  Maternal 71 
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anthropometric (height and weight) and clinical measurements (blood pressure, biological 72 
samples) were also collected.  Prior to 20 weeks’ gestation, maternal haemoglobin 73 
concentrations were measured and adjusted to account for cigarette smoking prior to/in early 74 
pregnancy in accordance with World Health Organisation (WHO) criteria.16, 17  Information on 75 
pregnancy outcomes (including preeclampsia, gestational diabetes mellitus (GDM)) were 76 
collected prospectively throughout pregnancy and validated subsequently. 77 
At birth, the mode of delivery was recorded and infants’ birth weight, length and head 78 
circumference were measured and customised birth weight centiles for the population were 79 
developed.  SGA was defined as a birth weight <10th customised centile adjusted for maternal 80 
height, booking weight, ethnicity, infant gestation and sex.18  Data was entered at the time of 81 
appointments into an internet-based, secure, custom database developed by Medical Science 82 
Online (MedSciNet, Sweden) and monitored extensively to avoid illogical or erroneous data. 83 
Biological samples 84 
At birth, umbilical cord blood was collected from BASELINE Study participants, processed to 85 
serum within three hours of collection and stored at -80°C until use.  Serum ferritin and high 86 
sensitivity C-reactive protein (CRP) were measured in the laboratory of the Cork Centre for 87 
Vitamin D and Nutrition Research, University College Cork, by immunoturbidimetric assay 88 
using the RX Monaco Clinical Chemistry Analyser (Randox Laboratories Ltd., Co. Antrim, 89 
UK).  Participants with an elevated CRP (>5 mg/L) were excluded.19 90 
Statistical analysis 91 
Data were analysed using IBM SPSS® for Windows™ version 21 (IBM Corp., Armonk, NY, 92 
USA).  Descriptive statistics were generated and normative distribution of the data was 93 
examined by skewness/kurtosis.  Differences between groups were explored by Chi square (χ2) 94 
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tests and independent t-tests or non-parametric tests for continuous variables, depending on 95 
their distribution.  Associations with cord ferritin concentrations were explored using 96 
Spearman correlations. 97 
Multiple linear regression models were developed to explore potential factors associated with 98 
cord serum ferritin concentrations.  Factors were first explored in unadjusted models and those 99 
with a P <0.1 were included in the final multivariate model (gender included as an a priori 100 
variable).  The residuals of the final linear regression model were normally distributed and 101 
associations were expressed as adjusted mean differences and 95% confidence intervals (CI).  102 
In a secondary analysis, crude and adjusted logistic regression models were developed to 103 
explore factors associated with low iron stores at birth, indicated by cord ferritin concentrations 104 
<76 µg/L.10  Unadjusted and final adjusted models were developed using the same protocol as 105 
for the linear regression analysis and associations were expressed as odds ratios (OR) and 95% 106 
CI.  Analyses were performed on complete datasets only, without recoding or imputation of 107 
missing values. 108 
Potential factors explored in the univariate analyses included maternal data collected at 15 109 
weeks’ gestation including education, employment, household income, relationship status, iron 110 
supplement use, haemoglobin concentrations, smoking status, alcohol consumption, physical 111 
activity levels, BMI, complications during pregnancy (preeclampsia, GDM), maternal age at 112 
delivery, mode of delivery and infant gender, gestational age, birth weight, length, head 113 





Of the 1 537 infants initially recruited antenatally to the BASELINE Study, 1 436 participated 117 
in the first study assessment.  At the time of this analysis, umbilical cord blood samples were 118 
available for 1 050 of these participants.  As the measurement of ferritin concentrations in 119 
umbilical cord blood serum samples was not an a priori objective of the BASELINE Study and 120 
given the restrictions on the availability of samples, a subsample of the cohort (n = 413) was 121 
selected to have cord ferritin concentrations measured, if they had 1) a complete maternal-122 
infant dataset and 2) matched blood samples collected at the 24-month study assessment (n = 123 
706 with samples).  The principal characteristics of those with cord ferritin concentrations 124 
measured and their comparison with the rest of the BASELINE cohort are presented in Table 125 
1. 126 
The distribution of cord serum ferritin concentrations in the 413 participants and in males and 127 
females separately is presented in Table 2.  Using the previously suggested thresholds for 128 
neonatal ferritin concentrations, low iron stores (ferritin <76 µg/L10) were observed in 8% (n = 129 
33) and iron deficiency (ferritin <35 µg/L11) was observed in 2% (n = 9) of participants. 130 
Maternal and antenatal factors 131 
Maternal BMI at 15 weeks’ gestation was inversely associated with cord ferritin concentrations 132 
(Spearman r = -0.157, P <0.0001).  Given the previously reported health consequences of 133 
maternal obesity in pregnancy,20 we looked specifically at the association between a maternal 134 
BMI ≥30 kg/m2 at 15 weeks’ gestation and cord ferritin.  Infants of obese mothers had lower 135 
median [interquartile range (IQR)] cord ferritin concentrations (137.8 [110.9, 178.3] vs. 198.3 136 
[137.1, 390.0] µg/L, P <0.0001) and a higher proportion of them had concentrations <76 µg/L 137 
(16.0 vs. 6.9%, P = 0.05) than infants whose mothers were not obese.  Infants born to mothers 138 
who were smoking at 15 weeks’ gestation had lower cord ferritin than non-smokers (160.2 139 
[115.5, 360.8] vs. 187.8 [135.3, 386.7] µg/L, P = 0.08), while a higher proportion of infants 140 
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born to smoking mothers had concentrations <76 µg/L (17.0 vs. 6.7%, P = 0.022).  Neither 141 
maternal alcohol consumption nor physical activity levels at 15 week’s gestation were 142 
associated with cord ferritin concentrations. 143 
Preeclampsia (systolic blood pressure ≥140 mm Hg or diastolic ≥90 mm Hg, or both, after 20 144 
weeks’ gestation, with either proteinuria or any multisystem complication) was diagnosed in 145 
3.4% (n = 14) of mothers.  Infants of mothers with preeclampsia had lower ferritin 146 
concentrations at birth than those without preeclampsia (141.8 [93.2, 234.2] vs. 187.5 [133.4, 147 
386.5] µg/L, P = 0.052).  Sixteen (3.9%) mothers were diagnosed with GDM; infants born to 148 
mothers with GDM had median [IQR] ferritin concentrations of 144.5 [92.1, 350.5] µg/L 149 
compared to 187.2 [133.3, 386.0] µg/L in the rest of the sample (P = 0.259). 150 
The median [IQR] haemoglobin concentration of mothers in early pregnancy was 129.0 [124.0, 151 
136.0] g/L and 1.7% (n = 7) had concentrations <110 g/L, indicative of anaemia.19  There was 152 
no association between maternal haemoglobin and cord ferritin concentrations.  Three-quarters 153 
(75.6%) of mothers took iron-containing supplements during their pregnancy, although the 154 
dose and duration of use of these supplements was not recorded.  Iron supplement users had 155 
cord ferritin concentrations of 193.3 [137.7, 386.8] µg/L and non-users had concentrations of 156 
174.8 [117.9, 397.5] µg/L (P = 0.146). 157 
Birth-associated factors 158 
Infants delivered vaginally had higher cord ferritin than those delivered by Caesarean section 159 
(193.1 [136.1, 394.8] vs. 162.6 [111.2, 334.5] µg/L, P = 0.005).  The prevalence of 160 
concentrations <76 µg/L among infants delivered vaginally was about half that of infants 161 
delivered by Caesarean section (6.5 vs. 12.6%, P = 0.089).  There was no difference in cord 162 
ferritin between infants delivered by elective (n = 28) or emergency Caesarean section. 163 
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Ferritin concentrations were lower in preterm infants (159.7 [110.5, 237.2] µg/L) than term 164 
infants (186.5 [132.9, 385.7] µg/L, P = 0.511), although only 15 infants in this study were born 165 
premature.  Neither weight, length or head circumference at birth was associated with cord 166 
ferritin.  SGA and non-SGA infants had similar cord ferritin concentrations (166.8 [101.9, 167 
372.9] vs. 188.5 [133.2, 386.7] µg/L, P = 0.166), however, more SGA infants had cord ferritin 168 
<76 µg/L (20.0 vs. 6.9%, P = 0.016) and <35 µg/L (14.3 vs. 1.1%, P <0.0001), respectively. 169 
Factors associated with cord serum ferritin concentrations 170 
Factors associated with cord ferritin concentrations included in the final linear regression 171 
model, expressed as the unadjusted and adjusted mean difference in µg/L (95% CI) are 172 
presented in Table 3.  Maternal BMI at 15 weeks’ gestation (kg/m2) was inversely associated 173 
with cord ferritin concentrations (-5.1 [-8.4, -1.7] µg/L, P = 0.003), with the effect of maternal 174 
obesity most notable.  Delivery by Caesarean section was associated with decreased cord 175 
ferritin concentrations, while the adverse effect of maternal smoking at 15 weeks’ gestation 176 
was attenuated in the final adjusted model.  In a separate model, maternal obesity combined 177 
with delivery by Caesarean section (n = 17) had a pronounced negative influence on cord 178 
ferritin (-81.5 [-147.2, -15.8] µg/L, P = 0.015). 179 
Factors associated with the risk of low iron stores at birth (ferritin <76 µg/L) included in the 180 
final logistic regression model are depicted in Table 4, displayed as both unadjusted and 181 
adjusted OR and 95% CI.  From the final adjusted model, infants born SGA were three times 182 
more likely to have low iron stores at birth in comparison to non-SGA infants, while maternal 183 
smoking during pregnancy and delivery by Caesarean section were also associated with an 184 
increased risk of low iron stores at birth.  The adverse effect of maternal obesity was attenuated 185 




This study has explored multiple potential factors that are associated with iron stores at birth 188 
in a large, prospective maternal-infant birth cohort.  Delivery by Caesarean section, being born 189 
SGA and an unhealthy maternal lifestyle, characterised by smoking and obesity during 190 
pregnancy, were all associated with significantly lower ferritin concentrations and an increased 191 
risk of low iron stores at birth in this cohort. 192 
A number of studies have explored individual determinants of cord ferritin concentrations in 193 
isolation.21-23  However, few studies have explored multiple potential determinants in a single 194 
cohort and those that have, have been somewhat limited by smaller sample sizes or a reliance 195 
on retrospectively collected data.9, 24, 25  Much of the focus of previous research has been on 196 
the influence of maternal iron status during pregnancy on neonatal iron status.  In this study, 197 
we observed no association between maternal anaemia in early pregnancy and cord ferritin 198 
concentrations, in contrast to findings in a number of early studies.26-28 199 
Maternal BMI at 15 weeks’ gestation and maternal obesity in particular was inversely 200 
associated with cord ferritin concentrations in the current study.  Obesity in pregnancy has been 201 
associated with an increased risk of suboptimal pregnancy outcomes and adverse health 202 
outcomes for both the mother and infant.20  With regards its effect on neonatal iron status, only 203 
four studies, all recent, have explored such associations.29-32  The mechanism behind this 204 
association remains to be fully elucidated but many suggested mechanisms involve the iron 205 
transporter protein, hepcidin.  The low-grade, chronic pro-inflammatory state associated with 206 
obesity results in an overexpression of hepcidin, inhibiting intestinal iron absorption and the 207 
release of iron from hepatic stores, thus decreasing circulating iron in the mother.29  Hepcidin 208 
may also interfere directly with placental iron transfer to the fetus, resulting in less maternal 209 
iron available to the fetus.29, 30  In addition, obesity during pregnancy is often associated with 210 
the concurrent diagnosis of other conditions that impact on neonatal iron status independently, 211 
including GDM, hypertension and preeclampsia.20, 33 212 
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Infants born by Caesarean section had significantly lower cord ferritin concentrations and an 213 
increased risk of low iron stores at birth compared to those delivered vaginally.  Delivery by 214 
Caesarean section has previously been shown to result in a decreased level of iron-related 215 
haematological indices, including haemoglobin, haematocrit and erythrocyte, in neonatal cord 216 
or peripheral blood compared to infants delivered vaginally.34  However, our study is one of 217 
the first to demonstrate the effect of Caesarean delivery on neonatal iron stores specifically.  218 
Caesarean deliveries result in a reduced placental transfusion attributable to a weaker 219 
transfusion force, mainly due to a lack of utero squeezing and gravity, and a shorter transfusion 220 
period due to immediate umbilical cord clamping.34, 35  The cumulative adverse effect of 221 
Caesarean delivery in obese mothers reported in the current study is also of particular 222 
importance, given the elevated rates of Caesarean deliveries observed in obese mothers.20  223 
Delayed clamping of the umbilical cord (≥180 seconds or after cord pulsations stop) has been 224 
shown to result in an increased transfusion of blood to the neonate, improving iron status with 225 
no associated increased risks of neonatal mortality or morbidity.36  Despite delayed cord 226 
clamping now being recommended as standard care for full term deliveries after uncomplicated 227 
pregnancies,37, 38 the practice is still not yet universal. 228 
The intrauterine environment has previously been shown to influence neonatal iron status, with 229 
smoking during pregnancy associated with chronic fetal hypoxia and decreased utero-placental 230 
blood flow.22  In this study, maternal smoking in early pregnancy was associated with an 231 
increased risk of low iron stores at birth, in agreement with previous observations.9, 23  232 
Additionally, we observed that infants born SGA, often due to growth restriction in utero, were 233 
three times more likely to have low iron stores at birth.  Of the infants with cord ferritin <35 234 
µg/L, a threshold suggested to reflect neonatal iron deficiency, over half were born SGA, 235 
further emphasising the influence of the intrauterine environment on neonatal iron stores. 236 
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This large, prospective study has identified a number of potentially modifiable lifestyle factors 237 
that impact neonatal iron stores.  The implications of such findings are important as firstly, low 238 
iron stores at birth track through to early childhood8, 9 and secondly, low iron stores at birth 239 
have previously been associated with adverse neurodevelopmental outcomes in childhood.10, 11  240 
The identification of specific risk factors for low iron stores at birth may help clinicians identify 241 
the infants most at risk, thus potentially enabling earlier intervention to prevent iron deficiency 242 
and its associated consequences, especially for neurodevelopment, later in childhood. 243 
The importance of overall maternal health and lifestyle for neonatal iron status has been 244 
highlighted.  The effect of maternal obesity reported in this study is particularly important, 245 
given its possible cumulative detrimental effect and the rising prevalence of obesity in pregnant 246 
women,39 the potential for a concomitant rise in iron deficiency rates in neonates is of concern.  247 
Public health policies and health promotion interventions for women of child-bearing age are 248 
needed with the promotion of a healthy lifestyle among young women essential to protect 249 
future generations. 250 
The current study has several strengths.  To our knowledge, this is the largest study to describe 251 
maternal, antenatal and birth-associated factors that influence serum ferritin concentrations at 252 
birth in a single prospective maternal-infant cohort.  The prospective, longitudinal design of 253 
both the SCOPE study and the Cork BASELINE Birth Cohort, with the collection of a detailed 254 
dataset for participants from 15 weeks' gestation has enabled this novel exploration.  The 255 
generalizability of our results may be somewhat limited, given the specific inclusion criteria of 256 
the cohort; however, they are generalizable to other healthy, low risk maternal-infant 257 
populations.  The low prevalence of certain pregnancy outcomes such as GDM and 258 
preeclampsia in this healthy cohort may have limited our ability to accurately investigate their 259 
influence on neonatal iron stores, while the lack of data collected on maternal serum ferritin 260 
concentrations or other indicators of iron status and diet during pregnancy is another limitation.  261 
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No information on the timing of umbilical cord clamping was recorded, however, delayed cord 262 
clamping was not routine in our service during the study period. 263 
Conclusions 264 
In this large, prospective maternal-infant cohort, we have identified a number of potentially 265 
modifiable lifestyle factors that influence iron stores at birth.  In particular, the important role 266 
of overall maternal health and lifestyle as opposed to iron status has been emphasised.  Given 267 
the reported consequences of low iron stores at birth for later iron status and developmental 268 
outcomes, strategies to improve neonatal iron status should be considered.  Public health 269 
policies targeting young women to improve nutrition and health outcomes and the universal 270 
implementation of delayed cord clamping in the obstetric field are two potential strategies.271 
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Table 1 Principal characteristics of participants with (n = 413) and without (n = 1023) cord 




(n = 413) 
Cord ferritin 
not measured 
(n = 1023) 
p value* 
Maternal characteristics    
Age (at delivery, years) 31.0 [29.0, 33.0] 31.0 [28.0, 33.0] 0.560 
Caucasian 409 (99) 993 (98) 0.266 
Education   0.920 
  ≤12 years 48 (12) 114 (11)  
  >12 years 365 (88) 898 (89)  
Marital status   0.264 
  Single 21 (5) 70 (7)  
  Married/defacto 392 (95) 953 (93)  
Household income   0.298 
  <€21,000 34 (9) 68 (7)  
  €21,000-€63,000 175 (44) 385 (40)  
  €64,000-€105,000 144 (36) 389 (40)  
  >€105,000 45 (11) 123 (13)  
Body mass index (kg/m2)   0.124 
  <18.5 3 (1) 11 (1)  
  ≥18.5 and <25.0 227 (55) 620 (61)  
  ≥25.0 and <30.0 133 (32) 268 (26)  
  ≥30.0 50 (12) 123 (12)  
Smoking   0.640 
  Never in pregnancy 308 (75) 771 (75)  
  Quit while pregnant 64 (15) 166 (16)  
  Still smoking 41 (10) 86 (9)  
Alcohol consumption   0.655 
  Never in pregnancy 74 (18) 190 (19)  
  Quit while pregnant 277 (67) 662 (65)  
  Still drinking 62 (15) 171 (16)  
Mode of delivery   0.036 
  Caesarean section 95 (24) 259 (29)  
  Vaginal 306 (76) 618 (71)  
Infant characteristics    
Male 221 (54) 507 (50) 0.195 
Preterm birth (<37 weeks) 15 (4) 56 (6) 0.241 
Small-for-gestational age 35 (9) 113 (11) 0.174 
Birth weight (kg) 3.5 [3.3, 3.8] 3.4 [3.1, 3.8] 0.033 
Birth length (cm) 50.5 [49.0, 51.9] 50.1 [48.9, 51.8] 0.051 
Head circumference at birth (cm) 35.0 [34.0, 36.0] 35.0 [34.0, 36.0] 0.599 
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Data presented as median [IQR] or numbers (%).  Maternal data collected at 15 weeks' 
gestation unless otherwise stated. 




Table 2 Distribution of cord serum ferritin concentrations (µg/L) in total population and in 
males and females separately 
  All Males Females 
  n = 413 n = 221 n = 192 
Mean 236.5 227.7 246.5 
SD 136.1 134.9 137.1 
Median 185.7 176.5 188.5 
5th centile 58.7 52.7 67.7 
25th centile 131.7 124.5 137.5 
75th centile 385.5 379.9 393.9 
95th centile 446.8 440.6 452.2 




Table 3 Factors associated with cord serum ferritin concentrations (µg/L) in infants in the 








(µg/L, 95% CI) 
p value 
BMI     
  <30 kg/m2 Reference  Reference  
  ≥30 kg/m2 -79.3 (-118.9, -39.6) <0.0001 -76.5 (-118.7, -34.3) <0.0001 
Smoking status     
  Non-smoker Reference  Reference  
  Smoker -39.9 (-83.9, 3.9) 0.074 -42.6 (-90.4, 5.2) 0.080 
Mode of delivery     
  Vaginal Reference  Reference  
  Caesarean section -42.7 (-73.9, -11.5) 0.008 -38.8 (-70.2, -7.4) 0.016 
Maternal data collected at 15 weeks' gestation unless otherwise stated. 
1 Final model included infant sex, gestational age, maternal education, income, BMI, 




Table 4 Factors associated with low iron stores (ferritin <76 µg/L) at birth in infants in the 
Cork BASELINE Birth Cohort Study (n = 413) 
Characteristic Unadjusted OR (95% CI) p value 
Adjusted OR1 
(95% CI) p value 
Smoking status     
  Non-smoker Reference  Reference  
  Smoker 2.8 (1.2, 6.5) 0.014 2.9 (1.2, 7.0) 0.020 
BMI     
  <30 kg/m2 Reference  Reference  
  ≥30 kg/m2 2.6 (1.1, 6.1) 0.031 1.8 (0.7, 4.6) 0.193 
Mode of delivery     
  Vaginal Reference  Reference  
  Caesarean section 2.1 (0.9, 4.4) 0.060 2.2 (1.0, 4.9) 0.046 
Small-for-gestational age infant      
  No Reference  Reference  
  Yes 3.4 (1.4, 8.5) 0.009 3.4 (1.3, 8.9) 0.012 
Maternal data collected at 15 weeks' gestation unless otherwise stated. 
1 Final model included infant sex, small-for-gestational age, maternal education, income, 
BMI, smoking and mode of delivery. Reference: cord ferritin concentrations ≥76 µg/L. 
 
